Staidson (Beijing) BioPharmaceuticals (300204.SZ) Earnings Analysis
Staidson (Beijing) BioPharmaceuticals (300204.SZ) has no confirmed upcoming earnings date. Trailing P/E -141.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300204.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300204.SZ. This page updates as the calendar is published.
300204.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-16 | -0.28356 CNY | n/a | n/a | n/a |
| 2025-03-31 | -0.00489 CNY | n/a | n/a | n/a |
| 2024-09-28 | -0.01244 CNY | n/a | n/a | n/a |
300204.SZ valuation and analyst view
| Trailing P/E | -141.27 |
|---|---|
| Trailing EPS | -0.17552 CNY |
| Price / book | 14.42 |
| Dividend yield | 0.00% |
| Market cap | 11.98B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Staidson (Beijing) BioPharmaceuticals (300204.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300204.SZ. This page updates as the calendar is published.
Did 300204.SZ beat earnings last quarter?
Consensus estimate data was not available for 300204.SZ's 2025-04-16 report.
What is 300204.SZ's current P/E ratio and EPS?
300204.SZ trades at a trailing P/E of -141.27 on trailing EPS of -0.17552305196768786 CNY.
What do analysts rate 300204.SZ?
300204.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.